<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02188342</url>
  </required_header>
  <id_info>
    <org_study_id>HITCa</org_study_id>
    <nct_id>NCT02188342</nct_id>
  </id_info>
  <brief_title>Assessing The Effectiveness of a Preoperative High Intensity Interval Training Programme In Older Colorectal Cancer Patients</brief_title>
  <acronym>HITCa</acronym>
  <official_title>Effectiveness of Short Term, High Intensity, Interval Exercise Training in Older Colorectal Cancer Patients in Improving Preoperative Fitness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nottingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospitals of Derby and Burton NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Nottingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to determine whether an improvement in aerobic fitness, as&#xD;
      judged by an increase in VO2peak, can be achieved within 31 days via HIT programme in a group&#xD;
      of older, colorectal cancer patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      12 high intensity interval training exercise sessions on a static cycle ergometer, over a&#xD;
      period of 31 days. Each session lasts 18 minutes.&#xD;
&#xD;
      At the beginning and end of the study the following measures will be used to assess change in&#xD;
      fitness, body composition and muscle metabolism. DXA scan, USS of thigh, VO2 peak cycling&#xD;
      test, short performance battery tests, quality of life questionnaires and muscle biopsy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VO2 peak</measure>
    <time_frame>After 31 days of HIT</time_frame>
    <description>Mean difference in VO2 peak following a HIT programme</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anaerobic threshold</measure>
    <time_frame>After 31 days of HIT</time_frame>
    <description>Mean difference in anaerobic threshold following a HIT programme</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle protein synthesis</measure>
    <time_frame>After 31 days of HIT</time_frame>
    <description>Assessment of D2O evaluated muscle protein synthesis following HIT programme</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>After 31 days of HIT</time_frame>
    <description>DXA and USS assessed changes in lean muscle mass and architecture following a HIT programme</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility</measure>
    <time_frame>After 31 days of HIT</time_frame>
    <description>Determination of patient compliance and adherence to HIT programme</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>After 31 days of HIT</time_frame>
    <description>Quality of life and performance questionnaires to measure subjective outcomes (EQ-5D, IPAQ, DASI, WEMWBS)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Preoperative Care</condition>
  <condition>Colorectal Neoplasms</condition>
  <condition>Aged</condition>
  <condition>Exercise</condition>
  <arm_group>
    <arm_group_label>HIT exercise training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HIT</intervention_name>
    <description>12 HIT exercise sessions in 31 days on a stationary cycle ergometer</description>
    <arm_group_label>HIT exercise training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Confirmed colorectal cancer&#xD;
&#xD;
          -  Offered curative treatment by the Royal Derby Hospital NHS Foundation Trust Colorectal&#xD;
             Cancer Multidisciplinary Team&#xD;
&#xD;
          -  Male and female&#xD;
&#xD;
          -  18-88 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Uncontrolled hypertension (BP &gt; 160/100),&#xD;
&#xD;
          -  Angina,&#xD;
&#xD;
          -  Heart failure (class III/IV),&#xD;
&#xD;
          -  Cardiac arrthymias,&#xD;
&#xD;
          -  Right to left cardiac shunt,&#xD;
&#xD;
          -  Recent cardiac event,&#xD;
&#xD;
          -  Previous stroke/TIA,&#xD;
&#xD;
          -  Aneurysm (large vessel or intracranial),&#xD;
&#xD;
          -  Severe respiratory disease including pulmonary hypertension,&#xD;
&#xD;
          -  COPD/asthma with an FEV1 less than 1.5 l,&#xD;
&#xD;
          -  Coagulation disorders,&#xD;
&#xD;
          -  Scarring disorders.&#xD;
&#xD;
          -  Current neoadjuvant chemo/radiotherapy&#xD;
&#xD;
          -  Inability to complete the consent process Involvement in invasive research study in&#xD;
             previous 3 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>88 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Williams, BSc MBChB FRCA PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nottingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Nottingham</name>
      <address>
        <city>Derby</city>
        <state>Derbyshire</state>
        <zip>DE22 3DT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <study_first_submitted>July 10, 2014</study_first_submitted>
  <study_first_submitted_qc>July 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2014</study_first_posted>
  <last_update_submitted>July 26, 2017</last_update_submitted>
  <last_update_submitted_qc>July 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

